[Skip to Content]
[Skip to Content Landing]
Article
March 1960

2,5-Dihydroxyphenylpyruvic Acid and Collagen Diseases

Author Affiliations

Boston

First four co-authors are from the Departments of Dermatology, Tufts University School of Medicine and The Boston City Hospital (Dr. Appel, Chief); the others are from the Cancer Research Institute, New England Deaconess Hospital, Harvard Medical School.

AMA Arch Derm. 1960;81(3):447-452. doi:10.1001/archderm.1960.03730030105018
Abstract

Hypersensitivity to physical,1-3 chemical,4-6 and bacteriological7,8 substances, altered cellular metabolism,9-11 and endocrine abnormalities12,13 have been implicated in attempts to explain the pathogenesis of the various collagen diseases. The abnormal metabolism of phenylalanine and tyrosine has now been postulated by Nishimura et al.14,15 as a biochemical clue to the etiology of collagen diseases. The concept of collagen diseases by Klemperer et al.,16-18 which originally included acute disseminated lupus erythematosus, scleroderma, and later, dermatomyositis, has now been extended by Nishimura et al. to include Weber-Christian disease, chronic discoid lupus erythematosus, periarteritis nodosa, acrosclerosis, and rheumatoid arthritis. We were impressed with this proposition and have attempted a confirmation of their work.

In 59 cases of the above diseases studied by Nishimura et al., they detected a substance in the urine which they identified provisionally as 2,5-dihydroxyphenylpyruvic acid (hereafter designated 2,5-DHPPA). This substance was not found

×